Back to Journals » Breast Cancer: Targets and Therapy » Volume 9

Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib

Total article views   Abstract views HTML views PDF downloads Totals
4,778 Dovepress* 3,158 825+ 698 3,983
PubMed Central* 0 795 393 795
Totals 3,158 1,620 1,091 4,778
*Since 6 December 2017
+Since July 2016

View citations on PubMed Central and Google Scholar